Compare · ELV vs GRAL
ELV vs GRAL
Side-by-side comparison of Elevance Health Inc. (ELV) and GRAIL Inc. (GRAL): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ELV and GRAL operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $80.92B, about 26.0x GRAL ($3.12B).
- Over the past year, ELV is up 35.0% and GRAL is up 111.2% - GRAL leads by 76.3 points.
- ELV has been more active in the news (6 items in the past 4 weeks vs 4 for GRAL).
- ELV has more recent analyst coverage (23 ratings vs 12 for GRAL).
PerformanceELV+34.97%GRAL+111.25%
2025-07-21+0.00%2026-07-17
- Company
- Elevance Health Inc.
- GRAIL Inc.
- Price
- $372.94+0.02%
- $72.50+0.76%
- Market cap
- $80.92B
- $3.12B
- 1M return
- -6.26%
- +24.27%
- 1Y return
- +34.97%
- +111.25%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 6
- 4
- Recent ratings
- 23
- 12
ELV
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Latest ELV
- Director Peru Ramiro G bought $366,050 worth of shares (1,000 units at $366.05), increasing direct ownership by 10% to 10,908 units (SEC Form 4)
- President and CEO Boudreaux Gail bought $1,002,230 worth of shares (2,725 units at $367.79), increasing direct ownership by 2% to 171,976 units (SEC Form 4)
- SEC Form 10-Q filed by Elevance Health Inc.
- Elevance Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Elevance Health Reports Second Quarter 2026 Results; Raises Full-Year Guidance
- Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter 2026 Results on July 15, 2026
- New Elevance Health Public Policy Institute Study Examines Payment Disputes for Planned Procedures Under the No Surprises Act
- Thomas Carr Howe Middle School Unveils New Fitness and Strength Training Space Through Partnership with Elevance Health and Impact Fitness Foundation
- Elevance Health Makes Clinical Review Faster, More Connected with Health OS
- SEC Form 11-K filed by Elevance Health Inc.
Latest GRAL
- Director Chase William J was granted 276 shares, increasing direct ownership by 0.65% to 42,978 units (SEC Form 4)
- Director Summe Gregory L was granted 427 shares, increasing direct ownership by 0.94% to 45,672 units (SEC Form 4)
- Director Mizell Steven was granted 268 shares, increasing direct ownership by 0.63% to 42,830 units (SEC Form 4)
- Priority Health Collaborates With GRAIL as the First Michigan Health Plan to Offer the Galleri® Multi-Cancer Early Detection Blood Test to Employer Plans
- GRAIL Completes $110 Million Equity Financing With Samsung Entities
- Director Mizell Steven was granted 5,491 shares, increasing direct ownership by 15% to 42,562 units (SEC Form 4)
- Director Chase William J was granted 5,491 shares, increasing direct ownership by 15% to 42,702 units (SEC Form 4)
- Director Summe Gregory L was granted 5,491 shares, increasing direct ownership by 14% to 45,245 units (SEC Form 4)
- Director Krevans Sarah was granted 5,491 shares, increasing direct ownership by 15% to 42,628 units (SEC Form 4)
- GRAIL Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders